methyl 3-amino-4,4-dimethoxybut-2-enoate

We are methyl 3-amino-4,4-dimethoxybut-2-enoate CAS:85396-57-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:methyl 3-amino-4,4-dimethoxybut-2-enoate
CAS.NO:85396-57-2
Synonyms:methyl 3-amino-4,4-dimethoxybut-2-enoate
methyl 4,4-dimethoxy-3-aminocrotonate
methyl 3-amino-4,4-dimethoxycrotonate
2-Butenoic acid,3-amino-4,4-dimethoxy-,methyl ester
methyl 3-amino-4,4-dimethoxy-2-butanoate
 
Physical and Chemical Properties:
Molecular Formula C7H13NO4
Molecular Weight 175.18200
 
Specification:
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Nilvadipine(CAS:75530-68-6) and Bazedoxifene(CAS:198481-32-2).

methyl 3-amino-4,4-dimethoxybut-2-enoate


Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.Dietilfosforoditioato CAS:298-06-6 On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.Cloruro de 2-furoilo CAS:527-69-5 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.

Related Products
Product Name
3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide View Details
6-amino-4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-7-ethoxyquinoline-3-carbonitrile View Details
Iron(III) Acetylacetonate Cas:14024-18-1 View Details
5-Trifluoromethyl-1H-indole-2-carboxylic acid manufacturer Sodium Oleate manufacturer 3-​Pyridinecarboxamide manufacturer 2′,3′-O-Isopropylideneadenosine manufacturer 3,4-Difluorobenzoic acid manufacturer